Delta Health could cut up to $400,000 per month in expenses after gaining access to the 340B Drug Pricing Program earlier this summer. The federal program requires prescription drug manufacturers participating in Medicaid to provide outpatient drugs at reduced costs to covered health entities.

The hospital gained access on July 1, nearly three months earlier than initial projections. CEO Matt Heyn credited Pharmacy Director Cari Dillon for securing the long-sought win, citing her “in-house” expertise as one reason for the early access.

Load comments